BIRC5 Promoter-Driven Nanodrugs Suppress BIRC5-Positive Cancers Independent of ABCB1 Status and IDO1 Expression.
Saved in:
| Title: | BIRC5 Promoter-Driven Nanodrugs Suppress BIRC5-Positive Cancers Independent of ABCB1 Status and IDO1 Expression. |
|---|---|
| Authors: | Chang YC; TMU Research Center of Cancer Translational Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Huang WL; Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.; Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan., Su WC; Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.; Department of Oncology, College of Medicine and Hospital, National Cheng Kung University, Tainan, Taiwan., Leung E; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Grafton, Auckland, New Zealand., Cheng FY; Department of Chemistry, College of Natural Science and Engineering, Chinese Culture University, Taipei, Taiwan., Cheung CHA; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan. |
| Source: | International journal of nanomedicine [Int J Nanomedicine] 2026 Apr 28; Vol. 21, pp. 588571. Date of Electronic Publication: 2026 Apr 28 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2013 (Electronic) Linking ISSN: 11769114 NLM ISO Abbreviation: Int J Nanomedicine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42088395 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: BIRC5 Promoter-Driven Nanodrugs Suppress BIRC5-Positive Cancers Independent of ABCB1 Status and IDO1 Expression. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chang+YC%22">Chang YC</searchLink>; TMU Research Center of Cancer Translational Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Huang+WL%22">Huang WL</searchLink>; Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.; Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Su+WC%22">Su WC</searchLink>; Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.; Department of Oncology, College of Medicine and Hospital, National Cheng Kung University, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Leung+E%22">Leung E</searchLink>; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Grafton, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Cheng+FY%22">Cheng FY</searchLink>; Department of Chemistry, College of Natural Science and Engineering, Chinese Culture University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Cheung+CHA%22">Cheung CHA</searchLink>; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101263847%22">International journal of nanomedicine</searchLink> [Int J Nanomedicine] 2026 Apr 28; Vol. 21, pp. 588571. <i>Date of Electronic Publication: </i>2026 Apr 28 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22DOVE+Medical+Press%22">DOVE Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101263847 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1178-2013 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211769114%22">11769114 </searchLink><i>NLM ISO Abbreviation: </i>Int J Nanomedicine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42088395 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2147/IJN.S588571 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 588571 Titles: – TitleFull: BIRC5 Promoter-Driven Nanodrugs Suppress BIRC5-Positive Cancers Independent of ABCB1 Status and IDO1 Expression. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chang YC – PersonEntity: Name: NameFull: Huang WL – PersonEntity: Name: NameFull: Su WC – PersonEntity: Name: NameFull: Leung E – PersonEntity: Name: NameFull: Cheng FY – PersonEntity: Name: NameFull: Cheung CHA IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 04 Text: 2026 Apr 28 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1178-2013 Numbering: – Type: volume Value: 21 Titles: – TitleFull: International journal of nanomedicine Type: main |
| ResultId | 1 |
